148 related articles for article (PubMed ID: 8115410)
1. Effects of dopamine antagonism on methamphetamine sensitization: evaluation by ambulatory activity in mice.
Kuribara H; Uchihashi Y
Pharmacol Biochem Behav; 1994 Jan; 47(1):101-6. PubMed ID: 8115410
[TBL] [Abstract][Full Text] [Related]
2. Dopamine antagonists can inhibit methamphetamine sensitization, but not cocaine sensitization, when assessed by ambulatory activity in mice.
Kuribara H; Uchihashi Y
J Pharm Pharmacol; 1993 Dec; 45(12):1042-5. PubMed ID: 7908972
[TBL] [Abstract][Full Text] [Related]
3. Can posttreatment with the selective dopamine D2 antagonist, YM-09151-2, inhibit induction of methamphetamine sensitization? Evaluation by ambulatory activity in mice.
Kuribara H
Pharmacol Biochem Behav; 1994 Oct; 49(2):323-6. PubMed ID: 7824544
[TBL] [Abstract][Full Text] [Related]
4. Modification of cocaine sensitization by dopamine D1 and D2 receptor antagonists in terms of ambulation in mice.
Kuribara H
Pharmacol Biochem Behav; 1995 Aug; 51(4):799-805. PubMed ID: 7675862
[TBL] [Abstract][Full Text] [Related]
5. Co-administration of either a selective D1 or D2 dopamine antagonist with methamphetamine prevents methamphetamine-induced behavioral sensitization and neurochemical change, studied by in vivo intracerebral dialysis.
Hamamura T; Akiyama K; Akimoto K; Kashihara K; Okumura K; Ujike H; Otsuki S
Brain Res; 1991 Apr; 546(1):40-6. PubMed ID: 1677305
[TBL] [Abstract][Full Text] [Related]
6. Dopamine D1 receptor antagonist SCH 23390 retards methamphetamine sensitization in both combined administration and early posttreatment schedules in mice.
Kuribara H
Pharmacol Biochem Behav; 1995 Dec; 52(4):759-63. PubMed ID: 8587917
[TBL] [Abstract][Full Text] [Related]
7. Effects of D2 or combined D1/D2 receptor antagonism on the methamphetamine-induced one-trial and multi-trial behavioral sensitization of preweanling rats.
Mohd-Yusof A; Veliz A; Rudberg KN; Stone MJ; Gonzalez AE; McDougall SA
Psychopharmacology (Berl); 2016 Mar; 233(5):893-903. PubMed ID: 26650612
[TBL] [Abstract][Full Text] [Related]
8. Caffeine enhances the stimulant effect of methamphetamine, but may not affect induction of methamphetamine sensitization of ambulation in mice.
Kuribara H
Psychopharmacology (Berl); 1994 Oct; 116(2):125-9. PubMed ID: 7862940
[TBL] [Abstract][Full Text] [Related]
9. SCH 23390 equivalently, but YM-09151-2 differentially reduces the stimulant effects of methamphetamine, MK-801 and ketamine: assessment by discrete shuttle avoidance in mice.
Kuribara H; Uchihashi Y
Jpn J Pharmacol; 1993 May; 62(1):111-4. PubMed ID: 8101884
[TBL] [Abstract][Full Text] [Related]
10. Role of dopamine D1-like receptors in methamphetamine locomotor responses of D2 receptor knockout mice.
Kelly MA; Low MJ; Rubinstein M; Phillips TJ
Genes Brain Behav; 2008 Jul; 7(5):568-77. PubMed ID: 18363855
[TBL] [Abstract][Full Text] [Related]
11. Effects of sulpiride and nemonapride, benzamide derivatives having distinct potencies of antagonistic action on dopamine D2 receptors, on sensitization to methamphetamine in mice.
Kuribara H
J Pharm Pharmacol; 1996 Mar; 48(3):292-6. PubMed ID: 8737056
[TBL] [Abstract][Full Text] [Related]
12. Inhibition of methamphetamine sensitization by post-methamphetamine treatment with SCH 23390 or haloperidol.
Kuribara H
Psychopharmacology (Berl); 1995 May; 119(1):34-8. PubMed ID: 7675947
[TBL] [Abstract][Full Text] [Related]
13. Effects of YM-09151-2, a potent and selective dopamine D2 antagonist, on the ambulation-increasing effect of methamphetamine in mice.
Kuribara H; Tadokoro S
Jpn J Pharmacol; 1990 Mar; 52(3):489-92. PubMed ID: 1970609
[TBL] [Abstract][Full Text] [Related]
14. Dopamine receptor antagonists prevent expression, but not development, of morphine sensitization.
Jeziorski M; White FJ
Eur J Pharmacol; 1995 Mar; 275(3):235-44. PubMed ID: 7768290
[TBL] [Abstract][Full Text] [Related]
15. Modification of morphine sensitization by opioid and dopamine receptor antagonists: evaluation by studying ambulation in mice.
Kuribara H
Eur J Pharmacol; 1995 Mar; 275(3):251-8. PubMed ID: 7768292
[TBL] [Abstract][Full Text] [Related]
16. Effects of haloperidol on the methamphetamine sensitization: assessment by ambulatory activity in mice.
Kuribara H; Uchihashi Y
Jpn J Psychiatry Neurol; 1993 Sep; 47(3):661-8. PubMed ID: 8301885
[TBL] [Abstract][Full Text] [Related]
17. The disruptive effects of ketamine on passive avoidance learning in mice: involvement of dopaminergic mechanism.
Uchihashi Y; Kuribara H; Isa Y; Morita T; Sato T
Psychopharmacology (Berl); 1994 Sep; 116(1):40-4. PubMed ID: 7862929
[TBL] [Abstract][Full Text] [Related]
18. Dopamine receptor antagonists fail to prevent induction of cocaine sensitization.
White FJ; Joshi A; Koeltzow TE; Hu XT
Neuropsychopharmacology; 1998 Jan; 18(1):26-40. PubMed ID: 9408916
[TBL] [Abstract][Full Text] [Related]
19. Sensitized increase of period gene expression in the mouse caudate/putamen caused by repeated injection of methamphetamine.
Nikaido T; Akiyama M; Moriya T; Shibata S
Mol Pharmacol; 2001 Apr; 59(4):894-900. PubMed ID: 11259635
[TBL] [Abstract][Full Text] [Related]
20. Effects of selective D-1 and D-2 dopamine antagonists on development of methamphetamine-induced behavioral sensitization.
Ujike H; Onoue T; Akiyama K; Hamamura T; Otsuki S
Psychopharmacology (Berl); 1989; 98(1):89-92. PubMed ID: 2498964
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
